Complete Filing Data
TriSalus Life Sciences, Inc. reported Net Income Loss of -$39.23 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean TriSalus Life Sciences, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$39.2M | -$30.0M | -$59.4M | -$47.2M | $4.8M |
| Operating Income Loss | -$26.9M | -$36.2M | -$54.5M | -$36.4M | -$3.0M |
| General And Administrative Expense | $21.5M | $18.0M | $23.5M | $12.5M | $3.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$39.2M | -$30.0M | -$59.4M | -$47.2M | $4.8M |
| Income Tax Expense Benefit | $7.0K | $6.0K | $9.0K | $9.0K | $0.00 |
| Research And Development Expense | $15.0M | $17.7M | $29.8M | $21.4M | |
| Net Income Loss Available To Common Stockholders Basic | -$69.7M | -$33.2M | -$63.6M | -$50.0M | |
| Selling And Marketing Expense | $28.7M | $25.8M | $17.0M | $12.7M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $45.2M | $29.4M | $18.5M | $12.4M | |
| Other Nonoperating Income Expense | -$456.0K | -$312.0K | -$378.0K | -$420.0K | |
| Gross Profit | $38.2M | $25.3M | $15.9M | $10.1M | |
| Cost Of Goods And Services Sold | $7.0M | $4.1M | $2.6M | $2.3M | |
| Nonoperating Income Expense | $8.9M | $7.8M | |||
| Interest Expense | $16.0K | $1.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$10.8M | -$8.3M | -$10.4M | -$2.4M | -$4.3M | -$13.2M | -$1.4M | -$14.0M | -$8.3M | -$8.1M | -$8.7M | -$7.9M | $1.9M | $378.9K | -$372.0K | -$711.4K | -$1.0K |
| Operating Income Loss | -$9.0M | -$7.3M | -$7.3M | -$8.7M | -$8.2M | -$11.7M | -$18.6M | -$11.4M | -$10.1M | -$8.1M | -$288.3K | -$669.8K | -$807.3K | -$783.9K | -$308.0K | -$108.5K | -$1.0K |
| General And Administrative Expense | $6.7M | $5.7M | $5.0M | $4.7M | $4.0M | $4.6M | $9.0M | $4.9M | $3.6M | $3.5M | $288.3K | $669.8K | $807.3K | $783.9K | $308.0K | $108.5K | $1.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$10.8M | -$8.3M | -$10.4M | -$2.4M | -$4.3M | -$13.2M | -$1.4M | -$14.0M | -$8.3M | -$8.1M | $2.4M | $2.8M | $1.9M | $378.9K | |||
| Income Tax Expense Benefit | $5.0K | -$3.0K | $5.0K | -$3.0K | $7.0K | $3.0K | $0.00 | $13.0K | -$5.0K | $0.00 | $28.2K | $0.00 | |||||
| Research And Development Expense | $5.2M | $3.9M | $3.3M | $4.2M | $4.7M | $5.8M | $9.5M | $6.9M | $5.6M | $4.8M | |||||||
| Net Income Loss Available To Common Stockholders Basic | -$41.3M | -$9.0M | -$11.1M | -$3.2M | -$5.1M | -$14.0M | -$1.9M | -$16.0M | -$9.2M | -$8.1M | |||||||
| Selling And Marketing Expense | $6.8M | $7.2M | $6.7M | $6.1M | $6.0M | $6.7M | $4.7M | $3.5M | $3.2M | $3.0M | |||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $11.6M | $11.2M | $9.2M | $7.3M | $7.4M | $6.5M | $5.2M | $4.6M | $3.0M | $3.9M | |||||||
| Other Nonoperating Income Expense | -$94.0K | -$40.0K | -$251.0K | -$13.0K | -$44.0K | -$153.0K | -$13.0K | -$25.0K | -$19.0K | -$31.0K | |||||||
| Gross Profit | $9.7M | $9.4M | $7.7M | $6.3M | $6.5M | $5.5M | $4.6M | $3.8M | $2.3M | $3.2M | |||||||
| Cost Of Goods And Services Sold | $1.9M | $1.8M | $1.5M | $1.0M | $912.0K | $971.0K | $589.0K | $772.0K | $662.0K | $701.0K | |||||||
| Nonoperating Income Expense | $477.7K | $422.4K | $1.3M | $2.7M | $3.5M | $2.7M | $1.2M | -$64.0K | -$602.9K | ||||||||
| Interest Expense | $877.0K | $3.0K | $4.0K | $4.0K | $5.0K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$33.9M | -$25.9M | -$27.1M | -$177.1M | -$129.6M | -$21.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $20.8M | $8.9M | $12.1M | $9.7M | $30.3M | $1.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $11.9M | -$3.3M | $2.5M | -$20.6M | -$1.1M | |
| Retained Earnings Accumulated Deficit | -$330.6M | -$279.5M | -$249.5M | -$186.4M | -$16.7M | -$21.5M |
| Liabilities And Stockholders Equity | $35.3M | $24.0M | $24.6M | $22.0M | $250.5M | $252.0M |
| Liabilities | $69.2M | $49.9M | $51.7M | $34.3M | $17.3M | $23.5M |
| Cash And Cash Equivalents At Carrying Value | $20.4M | $8.5M | $11.8M | $9.4M | $200.9K | $1.3M |
| Assets Current | $32.2M | $20.7M | $20.9M | $17.2M | $525.9K | $2.0M |
| Assets | $35.3M | $24.0M | $24.6M | $22.0M | $250.5M | $252.0M |
| Stockholder Equity | -$21.5M | |||||
| Liabilities Current | $11.5M | $10.2M | $14.7M | $32.4M | $1.6M | |
| Temporary Equity Carrying Amount Attributable To Parent | $164.0M | $160.5M | $250.0M | |||
| Preferred Stock Dividends Income Statement Impact | $0.00 | $3.2M | $1.3M | $0.00 | ||
| Accounts Receivable Net Current | $6.6M | $5.1M | $3.6M | $1.6M | ||
| Gain Loss On Sale Of Property Plant Equipment | -$120.0K | -$23.0K | -$44.0K | -$310.0K | ||
| Finance Lease Principal Payments | $81.0K | $84.0K | $87.0K | $131.0K | ||
| Derivative Liabilities Noncurrent | $12.9M | $8.3M | $17.1M | $369.0K | ||
| Accrued Liabilities Current | $8.1M | $7.4M | $10.6M | $6.4M | ||
| Business Combination Contingent Consideration Liability Noncurrent | $10.1M | $7.4M | $18.6M | |||
| Other Liabilities Current | $234.0K | $383.0K | $389.0K | $142.0K | ||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $2.7M | -$11.2M | -$10.3M | $0.00 | ||
| Other Assets Noncurrent | $418.0K | $423.0K | $466.0K | $367.0K | ||
| Inventory Net | $3.1M | $4.0M | $2.5M | $1.5M | ||
| Gain Loss On Equity Issuance | $0.00 | -$5.9M | -$8.3M | |||
| Common Stock Value | $4.0K | $3.0K | $2.0K | $0.00 | ||
| Operating Lease Right Of Use Asset | $861.0K | $1.2M | $1.2M | $1.4M | ||
| Lease Liability Noncurrent | $1.2M | $1.3M | $1.2M | $1.6M | ||
| Lease Liability Current | $167.0K | $216.0K | $351.0K | $370.0K | ||
| Deferred Offering Costs Noncurrent | $8.8M | |||||
| Accounts Payable Trade Current | $3.0M | $2.3M | $3.4M | $4.9M | ||
| Class Of Warrant Or Right Transfer Of Warrant To Preferred Stock | $0.00 | $25.4M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$26.7M | -$19.4M | -$34.4M | -$20.4M | -$25.3M | -$36.0M | $8.3M | -$198.4M | -$184.5M | -$153.9M | -$146.0M | -$137.4M | -$19.6M | $5.0M | $5.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $23.0M | $26.8M | $13.4M | $11.6M | $16.8M | $4.3M | $21.6M | $4.2M | $7.0M | $12.3M | $69.2K | $50.9K | $277.8K | $642.9K | $1.1M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $4.5M | -$7.8M | -$2.6M | -$150.0K | -$205.8K | $1.3M | |||||||||||||
| Retained Earnings Accumulated Deficit | -$321.0M | -$298.2M | -$289.9M | -$269.4M | -$265.9M | -$261.6M | -$212.9M | -$15.1M | -$13.9M | -$11.7M | -$11.5M | -$13.9M | -$19.6M | -$704.6K | -$1.1M | ||||
| Liabilities And Stockholders Equity | $36.5M | $41.3M | $28.6M | $27.5M | $32.4M | $17.9M | $33.6M | $12.2M | $20.5M | $251.3M | $250.6M | $250.4M | $250.8M | $251.2M | $251.8M | ||||
| Liabilities | $63.2M | $60.7M | $63.0M | $47.9M | $56.6M | $52.8M | $25.1M | $15.3M | $14.2M | $12.2M | $12.0M | $14.3M | $20.4M | $22.7M | $23.7M | ||||
| Cash And Cash Equivalents At Carrying Value | $22.7M | $26.5M | $13.0M | $11.3M | $16.5M | $4.0M | $21.4M | $104.0K | $136.8K | $207.6K | $69.2K | $50.9K | $277.8K | $642.9K | $1.1M | ||||
| Assets Current | $33.3M | $38.1M | $25.1M | $23.8M | $27.9M | $13.2M | $29.0M | $161.5K | $300.9K | $306.2K | $266.4K | $346.8K | $702.4K | $1.2M | $1.8M | ||||
| Assets | $36.5M | $41.3M | $28.6M | $27.5M | $32.4M | $17.9M | $33.6M | $12.2M | $20.5M | $251.3M | $250.6M | $250.4M | $250.8M | $251.2M | $251.8M | ||||
| Stockholder Equity | -$15.1M | -$13.9M | -$13.3M | -$11.7M | -$11.5M | -$13.9M | -$16.7M | -$19.6M | -$21.5M | -$21.9M | $24.0K | ||||||||
| Liabilities Current | $10.9M | $9.3M | $11.8M | $9.9M | $12.0M | $14.4M | $9.3M | $6.0M | $4.7M | $1.9M | $1.7M | $2.1M | |||||||
| Temporary Equity Carrying Amount Attributable To Parent | $204.0M | $20.2M | $164.0M | $250.0M | $250.0M | $250.0M | $223.5M | $223.1M | |||||||||||
| Preferred Stock Dividends Income Statement Impact | $0.00 | $714.0K | $712.0K | $803.0K | $801.0K | $801.0K | $458.0K | $0.00 | $0.00 | $0.00 | |||||||||
| Accounts Receivable Net Current | $5.0M | $5.6M | $5.5M | $4.9M | $4.7M | $4.3M | $3.1M | ||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | -$117.0K | -$18.0K | -$16.0K | ||||||||||||||||
| Finance Lease Principal Payments | $71.0K | $22.0K | $22.0K | ||||||||||||||||
| Derivative Liabilities Noncurrent | $12.8M | $10.0M | $9.5M | $7.8M | $12.5M | $14.6M | $28.9M | ||||||||||||
| Accrued Liabilities Current | $6.8M | $7.1M | $8.4M | $7.9M | $9.4M | $11.4M | $6.6M | $160.0K | $103.2K | ||||||||||
| Business Combination Contingent Consideration Liability Noncurrent | $5.0M | $7.5M | $8.2M | $6.6M | $8.9M | $22.6M | $28.9M | ||||||||||||
| Other Liabilities Current | $224.0K | $221.0K | $426.0K | $329.0K | $291.0K | $260.0K | $427.0K | ||||||||||||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -$2.5M | -$700.0K | $820.0K | -$2.4M | -$13.7M | $4.0M | -$19.9M | $0.00 | $0.00 | ||||||||||
| Other Assets Noncurrent | $419.0K | $419.0K | $424.0K | $424.0K | $424.0K | $424.0K | $367.0K | ||||||||||||
| Inventory Net | $3.3M | $3.8M | $4.2M | $4.0M | $3.4M | $2.9M | $1.6M | ||||||||||||
| Gain Loss On Equity Issuance | $0.00 | $0.00 | $0.00 | $0.00 | -$4.2M | -$1.5M | $0.00 | ||||||||||||
| Common Stock Value | $4.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | ||||||||||||
| Operating Lease Right Of Use Asset | $890.0K | $1.1M | $1.1M | $1.4M | $1.1M | $1.2M | $1.3M | ||||||||||||
| Lease Liability Noncurrent | $1.2M | $1.3M | $1.3M | $1.5M | $1.2M | $1.2M | $1.3M | ||||||||||||
| Lease Liability Current | $129.0K | $123.0K | $118.0K | $266.0K | $323.0K | $363.0K | $379.0K | ||||||||||||
| Deferred Offering Costs Noncurrent | $8.8M | $8.8M | $8.8M | $8.8M | $8.8M | $8.8M | $8.8M | $8.8M | $8.8M | $8.8M | |||||||||
| Accounts Payable Trade Current | $3.8M | $1.9M | $2.8M | $1.4M | $2.0M | $2.3M | $1.9M | ||||||||||||
| Class Of Warrant Or Right Transfer Of Warrant To Preferred Stock | $0.00 | $11.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$18.0M | -$40.8M | -$50.6M | -$32.3M | -$1.7M |
| Increase Decrease In Prepaid Expense | -$840.0K | $1.7M | -$1.0M | $2.6M | -$348.2K |
| Net Cash Provided By Used In Investing Activities | -$838.0K | -$345.0K | -$1.6M | -$1.8M | $60.0K |
| Net Cash Provided By Used In Financing Activities | $30.8M | $37.9M | $54.6M | $13.5M | $544.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.0M | -$4.4M | $2.8M | $5.2M | |
| Share Based Compensation | $9.1M | $5.4M | $1.4M | $368.0K | |
| Payments To Acquire Property Plant And Equipment | $918.0K | $345.0K | $588.0K | $655.0K | |
| Increase Decrease In Inventories | -$971.0K | $1.5M | $1.1M | $179.0K | |
| Increase Decrease In Accounts Receivable | $1.6M | $1.7M | $2.0M | $200.0K | |
| Increase Decrease In Operating Lease Liability | -$134.0K | -$278.0K | -$281.0K | -$87.0K | |
| Proceeds From Stock Options Exercised | $510.0K | $76.0K | $179.0K | $94.0K | |
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $0.00 | $9.2M | $13.5M | ||
| Proceeds From Warrant Exercises | $0.00 | $9.6M | $0.00 | ||
| Proceeds From Reverse Recapitalization | $0.00 | $36.9M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$4.5M | -$10.9M | -$10.5M | -$426.0K | -$205.8K | -$677.6K |
| Increase Decrease In Prepaid Expense | -$511.0K | -$955.0K | $348.0K | -$29.1K | -$45.4K | $673.2K |
| Net Cash Provided By Used In Investing Activities | -$714.0K | -$66.0K | -$74.0K | $11.0K | -$250.0M | |
| Net Cash Provided By Used In Financing Activities | $9.7M | $3.1M | $7.9M | $265.0K | $252.0M | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $1.6M | -$305.0K | $22.0K | $214.7K | $56.8K | |
| Share Based Compensation | $1.6M | $1.1M | $74.0K | |||
| Payments To Acquire Property Plant And Equipment | $754.0K | $66.0K | $7.0K | |||
| Increase Decrease In Inventories | $114.0K | $368.0K | $250.0K | |||
| Increase Decrease In Accounts Receivable | $366.0K | $723.0K | $35.0K | |||
| Increase Decrease In Operating Lease Liability | -$56.0K | -$85.0K | -$72.0K | |||
| Proceeds From Stock Options Exercised | $279.0K | $7.0K | $50.0K | |||
| Proceeds From Issuance Of Preferred Stock And Preference Stock | $0.00 | $3.2M | ||||
| Proceeds From Warrant Exercises | $0.00 | $4.7M | ||||
| Proceeds From Reverse Recapitalization |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $-1.84 | $-1.31 | $-6.77 | $-161.55 | ||
| Earnings Per Share Basic | $-1.84 | $-1.31 | $-6.77 | $-161.55 | ||
| Weighted Average Number Of Shares Outstanding Basic | 37.9M | 25.3M | 9.4M | 309.6K | ||
| Weighted Average Number Of Diluted Shares Outstanding | 37.9M | 25.3M | 9.4M | 309.6K | ||
| Preferred Stock Shares Issued | 0.00 | 4.0M | 4.0M | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 4.0M | 4.0M | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 50.0M | 31.3M | 26.4M | 347.9K | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Authorized | 400.0M | 400.0M | 400.0M | 30.9M | ||
| Common Stock Shares Issued | 50.0M | 31.3M | 26.4M | 347.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $-0.96 | $-0.27 | $-0.39 | $-0.12 | $-0.21 | $-0.60 | $-0.14 | $-35.84 | $-0.57 | $-25.95 | ||||||
| Earnings Per Share Basic | $-0.96 | $-0.27 | $-0.39 | $-0.12 | $-0.21 | $-0.60 | $-0.14 | $-35.84 | $-0.57 | $-25.95 | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 43.1M | 32.9M | 28.5M | 26.5M | 23.9M | 23.3M | 13.2M | 446.3K | 16.2M | 311.8K | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 43.1M | 32.9M | 28.5M | 26.5M | 23.9M | 23.3M | 13.2M | 446.3K | 16.2M | 311.8K | ||||||
| Preferred Stock Shares Issued | 0.00 | 3.6M | 3.6M | 4.0M | 4.0M | 4.0M | 4.0M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Shares Outstanding | 0.00 | 3.6M | 3.6M | 4.0M | 4.0M | 4.0M | 4.0M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 49.9M | 38.0M | 32.3M | 30.5M | 27.2M | 26.8M | 26.3M | |||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Common Stock Shares Authorized | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | |||||||||
| Common Stock Shares Issued | 49.9M | 38.0M | 32.3M | 30.5M | 27.2M | 26.8M | 26.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Investment Income Interest | $555.0K | $404.0K | $431.0K | $180.0K | $64.0K | |
| Prepaid Expense Current | $2.2M | $3.0M | $3.0M | $4.8M | $325.0K | $673.2K |
| Stock Issued During Period Value Stock Options Exercised | $510.0K | $76.0K | $180.0K | $94.0K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $9.8M | $5.4M | $1.4M | $368.0K | ||
| Stock Issued During Period Value New Issues | $20.5M | $15.5M | $34.2M | |||
| Additional Paid In Capital | $296.7M | $253.7M | $222.4M | $10.0M | ||
| Fair Value Adjustment Of Warrants | -$5.8M | -$7.7M | ||||
| Depreciation And Amortization | $626.0K | $744.0K | $684.0K | $398.0K | ||
| Derivative Gain Loss On Derivative Net | -$4.1M | -$2.1M | -$10.9M | -$2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $170.0K | $134.0K | $74.0K | $158.0K | $97.0K | $92.0K | $116.0K | $36.0K | $35.0K | $49.0K | $314.7K | $57.2K | $18.7K | $2.8K | $34.6K | $3.3K | |
| Prepaid Expense Current | $2.4M | $2.2M | $2.5M | $3.6M | $3.3M | $2.0M | $3.0M | $57.5K | $164.1K | $98.6K | $197.3K | $295.9K | $424.6K | $524.1K | $627.9K | ||
| Stock Issued During Period Value Stock Options Exercised | $88.0K | $56.0K | $279.0K | $2.0K | $5.0K | $7.0K | $29.0K | $16.0K | $50.0K | $7.0K | $5.0K | $61.0K | |||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $3.4M | $2.5M | $1.6M | $1.3M | $1.3M | $1.1M | $259.0K | $69.0K | $73.0K | $119.0K | $70.0K | $62.0K | |||||
| Stock Issued During Period Value New Issues | $20.7M | $5.6M | $3.6M | $3.1M | $34.2M | $25.0K | $25.0K | ||||||||||
| Additional Paid In Capital | $294.2M | $278.8M | $255.6M | $249.0M | $241.8M | $226.7M | $221.4M | $5.7M | $6.1M | $5.7M | |||||||
| Fair Value Adjustment Of Warrants | -$265.3K | -$265.3K | -$265.3K | -$2.4M | -$3.4M | -$2.7M | -$1.2M | $98.7K | $83.3K | ||||||||
| Depreciation And Amortization | $172.0K | $175.0K | $184.0K | ||||||||||||||
| Derivative Gain Loss On Derivative Net | -$758.0K | $2.5M | $2.4M |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.